Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review

BACKGROUND: Levetiracetam, a second-generation anti-epileptic drug (AED) with a good efficacy and safety profile, is licensed as monotherapy for adults and children older than 16 years with focal seizures with or without secondary generalization. However, it is increasingly being used off-label in y...

Descripción completa

Detalles Bibliográficos
Autores principales: Weijenberg, Amerins, Brouwer, Oebele F., Callenbach, Petra M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469086/
https://www.ncbi.nlm.nih.gov/pubmed/26013703
http://dx.doi.org/10.1007/s40263-015-0248-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469086/
https://www.ncbi.nlm.nih.gov/pubmed/26013703
http://dx.doi.org/10.1007/s40263-015-0248-9

Ejemplares similares